相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An expanded universe of cancer targets
William C. Hahn et al.
CELL (2021)
Comprehensive characterization of protein-protein interactions perturbed by disease mutations
Feixiong Cheng et al.
NATURE GENETICS (2021)
Hypomorph mutation-directed small-molecule protein-protein interaction inducers to restore mutant SMAD4-suppressed TGF-β signaling
Cong Tang et al.
CELL CHEMICAL BIOLOGY (2021)
Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma
Fazal Shirazi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effect of AKT1 (p. E17K) Hotspot Mutation on Malignant Tumorigenesis and Prognosis
Ying Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
A compendium of mutational cancer driver genes
Francisco Martinez-Jimenez et al.
NATURE REVIEWS CANCER (2020)
The BioGRID interaction database: 2019 update
Rose Oughtred et al.
NUCLEIC ACIDS RESEARCH (2019)
Systematic Functional Annotation of Somatic Mutations in Cancer
Patrick Kwok-Shing Ng et al.
CANCER CELL (2018)
COSMIC: somatic cancer genetics at high-resolution
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2017)
AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
Xiulei Mo et al.
MOLECULAR PHARMACOLOGY (2017)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies
Zenggang Li et al.
NATURE COMMUNICATIONS (2017)
New perspectives for targeting RAF kinase in human cancer
Zoi Karoulia et al.
NATURE REVIEWS CANCER (2017)
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
Matthew T. Chang et al.
NATURE BIOTECHNOLOGY (2016)
Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform
Xiu-Lei Mo et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2016)
The Fanconi anaemia pathway: newyplayers and new functions
Raphael Ceccaldi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Widespread Macromolecular Interaction Perturbations in Human Genetic Disorders
Nidhi Sahni et al.
CELL (2015)
Comprehensive assessment of cancer missense mutation clustering in protein structures
Atanas Kamburov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The mutational landscapes of genetic and chemical models of Kras-driven lung cancer
Peter M. K. Westcott et al.
NATURE (2015)
Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
Jacob R. Haling et al.
CANCER CELL (2014)
A Proteome-Scale Map of the Human Interactome Network
Thomas Rolland et al.
CELL (2014)
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Michelle R. Arkin et al.
CHEMISTRY & BIOLOGY (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Efficient NQO1 Substrates are Potent and Selective Anticancer Agents
Elizabeth I. Parkinson et al.
ACS CHEMICAL BIOLOGY (2013)
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
Melba C. Jaramillo et al.
GENES & DEVELOPMENT (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Yosef Shiloh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Targeting protein-protein interactions as an anticancer strategy
Andrei A. Ivanov et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
Alexander M. Menzies et al.
CLINICAL CANCER RESEARCH (2012)
Mutant p53 cooperates with ETS2 to promote etoposide resistance
Phi M. Do et al.
GENES & DEVELOPMENT (2012)
Mutual exclusivity analysis identifies oncogenic network modules
Giovanni Ciriello et al.
GENOME RESEARCH (2012)
Differential Sensitivity of Glioma-versus Lung Cancer-Specific EGFR Mutations to EGFR Kinase Inhibitors
Igor Vivanco et al.
CANCER DISCOVERY (2012)
NRF2 and cancer: the good, the bad and the importance of context
Michael B. Sporn et al.
NATURE REVIEWS CANCER (2012)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector
Albena T. Dinkova-Kostova et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Towards patient-based cancer therapeutics
Stuart L. Schreiber et al.
NATURE BIOTECHNOLOGY (2010)
P53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK
Karen A. Boehme et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM
JG Viniegra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage
ES Kandel et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Interaction of the fanconi anemia proteins and BRCA1 in a common pathway
I Garcia-Higuera et al.
MOLECULAR CELL (2001)
分享论文
